Biomarin Pharmaceutical (BMRN) Total Liabilities (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded Total Liabilities of $5.4 billion in Q2 2026, up 277.9% from $1.43 billion a year earlier and up 127.1% from the prior quarter.
Biomarin Pharmaceutical (BMRN) Total Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical reported Total Liabilities of $1.51 billion, up 13.2% from FY2024.
- Annual Total Liabilities has a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- Across earlier years, Total Liabilities came in at $1.33 billion in FY2024 (-29.6%), $1.89 billion in FY2023 (+6.7%), $1.77 billion in FY2022 (+1.9%) and $1.74 billion in FY2021 (-0.5%).
- The Q2 2026 figure is the highest quarterly Total Liabilities in data going back to Q4 2009.
- On a year-over-year basis, Total Liabilities has increased for four consecutive quarters, with growth averaging 34.8% over the last eight quarters.
- Peak year-over-year performance for Total Liabilities in the last five years was growth of 277.9% in Q2 2026, against a decline of 29.6% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.38 billion (Q1 2026), $1.51 billion (Q4 2025) and $1.56 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 116.09 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 141.05 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 87.82 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 80.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 65.46 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 83.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 37.53 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 115.64 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 7.18 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 5.40 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.40 Bn |
| Mar 31, 2026 | 2.38 Bn |
| Dec 31, 2025 | 1.51 Bn |
| Sep 30, 2025 | 1.56 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | 1.35 Bn |
| Dec 31, 2024 | 1.33 Bn |
| Sep 30, 2024 | 1.44 Bn |
| Jun 30, 2024 | 1.78 Bn |
| Mar 31, 2024 | 1.80 Bn |
| Dec 31, 2023 | 1.89 Bn |
| Sep 30, 2023 | 1.86 Bn |
| Jun 30, 2023 | 1.78 Bn |
| Mar 31, 2023 | 1.77 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 1.70 Bn |
| Jun 30, 2022 | 1.65 Bn |
| Mar 31, 2022 | 1.68 Bn |
| Dec 31, 2021 | 1.74 Bn |
| Sep 30, 2021 | 1.72 Bn |
Biomarin Pharmaceutical Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=BMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();